Suchergebnisse - (Subject:"Siltuximab")

PubPharm (47)

21

enthalten in: Advances in experimental medicine and biology | 2020

von Nair, R. | Westin, J.

22

Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature

enthalten in: Magyar onkologia | 2018

von Szegedi, I. | Gáspár, I. | Gyurina, K. | +2

23

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2018

von Masjedi, A. | Hashemi, V. | Hojjat-Farsangi, M. | +4

24

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

25

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

26

Investigational agents in immunotherapy : a new horizon for the treatment of multiple myeloma

enthalten in: British journal of haematology | 2018

von Varga, C. | Laubach, J. | Anderson, K. | +1

27

Impact of siltuximab on patient-related outcomes in multicentric Castleman's disease

enthalten in: Patient related outcome measures | 2018

von Sitenga, J. | Aird, G. | Ahmed, A. | +1

28

The Role of Interleukin-6 in Castleman Disease

enthalten in: Hematology/oncology clinics of North America | 2018

von Yoshizaki, K. | Murayama, S. | Ito, H. | +1

29

Treatment of Idiopathic Castleman Disease

enthalten in: Hematology/oncology clinics of North America | 2018

von van Rhee, F. | Greenway, A. | Stone, K.

30

Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma

enthalten in: Expert opinion on investigational drugs | 2017

von Ferrario, A. | Merli, M. | Basilico, C. | +2